MarketCap
Facebook
X
TelegramAnnual report 2023
added 04-16-2024
Advaxis P/B Ratio 2011-2026 | ADXS
Annual P/B Ratio Advaxis
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.113 | 0.116 | 39.8 | 0.602 | 0.198 | 0.878 | 2.23 | 2.47 | 2.93 | 2.59 | 1.09 | -3.23 | -2.7 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 39.8 | -3.23 | 3.62 |
P/B Ratio of other stocks in the Biotechnology industry
| Issuer | P/B Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
ARCA biopharma
ABIO
|
1.27 | - | 1052.0 % | $ 415 M |  USA |
 |
MorphoSys AG
MOR
|
1.28 | - | 2.43 % | $ 254 M |  Germany |
 |
Acorda Therapeutics
ACOR
|
0.154 | - | -24.86 % | $ 820 K | USA |
 |
Adagene
ADAG
|
1.74 | $ 3.96 | 1.28 % | $ 223 M |  China |
 |
AbCellera Biologics
ABCL
|
0.995 | $ 3.49 | -1.83 % | $ 1.04 B |  Canada |
 |
Acasti Pharma
ACST
|
0.612 | - | 4.01 % | $ 150 M | Canada |
 |
AC Immune SA
ACIU
|
1.32 | $ 3.2 | -3.61 % | $ 229 M |  Schweiz |
 |
I-Mab
IMAB
|
1.12 | - | - | $ 866 M | China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
2.88 | - | - | $ 40.3 B | USA |
 |
Biophytis SA
BPTS
|
15.7 | - | -13.47 % | $ 169 M |  France |
 |
Autolus Therapeutics plc
AUTL
|
0.991 | $ 1.47 | -2.65 % | $ 375 M |  Britain |
 |
BioCardia
BCDA
|
-5.55 | $ 1.3 | 1.56 % | $ 27.5 M | USA |
 |
Aeterna Zentaris
AEZS
|
0.781 | - | 5.93 % | $ 314 M | Canada |
 |
AgeX Therapeutics
AGE
|
0.00262 | - | -10.17 % | $ 12.2 K | USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
4.13 | - | -1.52 % | $ 24.7 M | USA |
 |
ADC Therapeutics SA
ADCT
|
7.34 | $ 4.06 | -1.22 % | $ 105 M | Schweiz |
 |
Aeglea BioTherapeutics
AGLE
|
1.4 | - | - | $ 1.01 B | USA |
 |
BioNTech SE
BNTX
|
5.29 | $ 91.92 | -3.1 % | $ 27.2 B | Germany |
 |
Applied Genetic Technologies Corporation
AGTC
|
0.382 | - | - | $ 26.5 M | USA |
 |
Midatech Pharma plc
MTP
|
7.56 | - | -18.52 % | $ 27.3 M | Britain |
 |
Adverum Biotechnologies
ADVM
|
1.08 | - | - | $ 86.2 M | USA |
 |
Aptorum Group Limited
APM
|
0.347 | $ 0.79 | -0.05 % | $ 4.31 M | China |
 |
Can-Fite BioPharma Ltd.
CANF
|
32 | $ 3.4 | -0.87 % | $ 7.4 B |  Israel |
 |
argenx SE
ARGX
|
5.43 | $ 691.62 | -2.04 % | $ 25 B |  Niderland |
 |
Catalyst Biosciences
CBIO
|
7.02 | $ 10.8 | -2.7 % | $ 965 M | USA |
 |
Certara
CERT
|
1.01 | $ 6.58 | -0.83 % | $ 1.06 B | USA |
 |
Akero Therapeutics
AKRO
|
4.34 | - | - | $ 3.67 B | USA |
 |
Akouos
AKUS
|
0.736 | - | 0.23 % | $ 488 M | USA |
 |
Coherus BioSciences
CHRS
|
3.71 | $ 1.62 | -3.61 % | $ 190 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
6.81 | - | - | - |  Russia |
 |
Ascendis Pharma A/S
ASND
|
8.34 | $ 226.93 | -0.5 % | $ 5 B |  Danmark |
 |
Albireo Pharma
ALBO
|
3.06 | - | -0.23 % | $ 916 M | USA |
 |
Alterity Therapeutics Limited
ATHE
|
125 | $ 3.51 | 5.18 % | $ 8.45 B |  Australia |
 |
Acer Therapeutics
ACER
|
-0.724 | - | 2.71 % | $ 14 M | USA |
 |
Allena Pharmaceuticals
ALNA
|
3.16 | - | 3.16 % | $ 1.9 M | USA |
 |
Aileron Therapeutics
ALRN
|
0.702 | - | 10.36 % | $ 9.8 M | USA |
 |
AlloVir
ALVR
|
-0.258 | - | 4.14 % | $ 49.1 M | USA |
 |
Collegium Pharmaceutical
COLL
|
4.63 | $ 35.01 | -1.99 % | $ 1.11 B | USA |
 |
Anika Therapeutics
ANIK
|
1.38 | $ 14.25 | -1.79 % | $ 209 M | USA |
 |
Aptinyx
APTX
|
0.248 | - | -39.0 % | $ 4.57 M | USA |
 |
Applied Molecular Transport
AMTI
|
0.364 | - | - | $ 10.1 M | USA |
 |
Aptose Biosciences
APTO
|
-0.511 | - | -45.71 % | $ 1.2 M | Canada |
 |
Arcturus Therapeutics Holdings
ARCT
|
1.01 | $ 6.48 | 1.41 % | $ 177 M | Israel |
 |
Burford Capital Limited
BUR
|
1.26 | $ 8.43 | 1.81 % | $ 1.36 B | Britain |
 |
CureVac N.V.
CVAC
|
5.13 | - | - | $ 867 M | Germany |
 |
Aravive
ARAV
|
5.67 | - | -13.39 % | $ 1.45 M | USA |
 |
Athira Pharma
ATHA
|
0.36 | - | - | $ 269 M | USA |
 |
Athersys
ATHX
|
11.6 | - | 3.77 % | $ 22.4 M | USA |
 |
Actinium Pharmaceuticals
ATNM
|
1.48 | $ 1.12 | -1.75 % | $ 33.7 M | USA |